China gives conditional approval to Sinopharm vaccine

By: |
December 31, 2020 9:18 AM

Chen Shifei, the deputy commissioner of China's Medical Production Administration, said at a news conference Thursday that the decision had been made the previous night.

china Sinopharm vaccine,covid 19The vaccine is an inactivated, two-dose vaccine from the Beijing Institute of Biological Products, a subsidiary of state-owned conglomerate Sinopharm. (Photo source: AP)

China has given conditional approval to a coronavirus vaccine developed by state-owned Sinopharm. The vaccine is the first one approved for general use in China.

Chen Shifei, the deputy commissioner of China’s Medical Production Administration, said at a news conference Thursday that the decision had been made the previous night.

The vaccine is an inactivated, two-dose vaccine from the Beijing Institute of Biological Products, a subsidiary of state-owned conglomerate Sinopharm. The company announced Wednesday that preliminary data from last-stage trials had shown it to be 79.3 per cent effective.

Sinopharm is one of at least five Chinese developers that are in a global race to create vaccines for the disease that has killed more than 1.8 million people.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Over 12.7 lakh healthcare workers received COVID-19 vaccine jabs Friday 6 pm
2Health worker dies days after jab; official says no vaccine link
3India undertaking contractual supplies of coronavirus vaccines to several countries: MEA